Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

HIF-2α translation inhibitor 76 is an inhibitor of hypoxia-inducible factor-2α (HIF-2α) translation.1 It inhibits constitutive gene expression in a hypoxia-response element (HRE) reporter assay using VHL-deficient 786-O renal cell carcinoma (RCC) cells (IC50 = 5 µM). HIF-2α translation inhibitor 76 reduces the translation of nascent HIF-2α mRNA in 786-O cells. Conditioned medium from 786-O cells preincubated with HIF-2α translation inhibitor 76 inhibits the proliferation of human umbilical vein endothelial cells (HUVECs). HIF-2α translation inhibitor 76 (10 nM) inhibits erythrocytosis and angiogenesis induced by DMOG (Item No. 71210) in zebrafish.2 It increases survival and right ventricle contractility and inhibits right ventricle hypertrophy in a rat model of pulmonary arterial hypertension induced by monocrotaline (Item No. 16666).3
WARNING This product is not for human or veterinary use.
1. Small-
2. Pharmacological HIF2α inhibition improves VHL disease-
3. Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-